Bowman v. SP Pharmaceuticals

Court of Appeals for the Tenth Circuit·Decided December 5, 2000·No. 99-2317·Unpublished

Opinion

F I L E D

United States Court of Appeals Tenth Circuit

UNITED STATES COURT OF APPEALS DEC 5 2000

TENTH CIRCUIT

PATRICK FISHER

Clerk

MATTHEW BOWMAN,

Plaintiff - Appellant, No. 99-2317 v. D. New Mexico SP PHARMACEUTICALS, L.L.C., (D.C. No. CIV-98-415-LH/RLP) a New Mexico company; SP ASSOCIATES, INC., a New Mexico corporation; H. JOSEPH LARSEN; DONALD E. HAGMAN; and FERNANDO A. CORREA da COSTA,

Defendants - Appellees.

ORDER AND JUDGMENT *

Before TACHA , ANDERSON , and BALDOCK , Circuit Judges.

Appellant Matthew F. Bowman brought this diversity action against SP Pharmaceuticals, L.L.C. (“SPLLC”), SP Associates, Inc. (“SPINC”), H. Joseph Larsen, Donald E. Hagman, and Fernando A. Correa da Costa after the individual defendants expelled him from a management buyout partnership (the “MBO

*

This order and judgment is not binding precedent, except under the doctrines of law of the case, res judicata, and collateral estoppel. The court generally disfavors the citation of orders and judgments; nevertheless, an order and judgment may be cited under the terms and conditions of 10th Cir. R. 36.3.

Partnership”). Appellant’s complaint asserted breach of fiduciary duty, fraud, prima facie tort, derivative usurpation of corporate opportunity and constructive trust claims. The district court granted Defendants’ motion for summary judgment on all claims, holding that (1) because Appellant and the individual defendants agreed to abandon SPINC, Appellant may not assert claims on its behalf, and (2) since any opportunity enjoyed by Appellant was contingent on obtaining financing, the bank’s independent decision not to finance a transaction involving Appellant requires that summary judgment be granted as to the breach of fiduciary duty and constructive trust claims.

On appeal, Appellant contends that the district court erred in granting summary judgment in favor of Defendants on the breach of fiduciary duty, fraud, derivative and constructive trust claims because: (1) regardless of the bank’s position, genuine issues of material fact exist as to whether the individual defendants breached their fiduciary duties to Appellant; (2) triable issues of fact exist regarding the individual defendants’ motives and state of mind when they represented to Appellant that he was a partner; (3) the court failed to take into consideration that the Letter of Intent (“LOI”) between SPINC and Pharmacia & Upjohn, Inc. (“P&U”) was never formally transferred to SPLLC; and (4) a constructive trust may arise because there are triable issues of fact as to whether

the individual defendants breached their fiduciary duties to Appellant. We exercise jurisdiction pursuant to 18 U.S.C. § 1291, and affirm.

I. BACKGROUND

In early 1996, the individual defendants formed the MBO Partnership to pursue the acquisition of a sterile injectable pharmaceuticals facility (the “Facility”) from P&U. Appellant agreed to become the fourth partner in the MBO Partnership in April of 1996. He was to be the vice president of sales and marketing of the acquiring entity and was to hold an equity share in that entity equal to that of each individual defendant. The partners agreed that Appellant would relocate from Ohio to New Mexico after the transaction closed in order to devote his full attention to the new venture.

On May 21, 1996, the four partners incorporated SPINC. Appellant and the

individual defendants were SPINC’s sole directors, officers and shareholders. 1 In

December of 1996, SPINC entered into the LOI with P&U. The LOI referred to Appellant as an officer and director of SPINC and stated that the LOI memorialized recent negotiations for the purchase of the Facility by “SP Associates, or its assignee, which will be controlled by the current owners of SP Associates, Inc.” Appellant’s App. at 280. The LOI provided that P&U would

1 The SPINC shares apparently were never issued.

sell the Facility to SPINC for $20,550,000 and that P&U would not, until the termination of the LOI, negotiate a sale of the Facility with any other buyer. The LOI was contingent on SPINC obtaining adequate financing.

In January of 1997, the four partners met to discuss the transaction. The results of those discussions are found in a letter from da Costa to Appellant, Larsen and Hagman dated January 28, 1997 (the “da Costa Letter”). The da Costa Letter states that the partners agreed to use NationsBank (“NB”) to finance the transaction. Id. at 290. In addition, the da Costa Letter states that the partners, who were SPINC’s sole directors, officers and shareholders, unanimously agreed to abandon that entity and use a limited liability company (“LLC”) as the acquisition vehicle. Id. at 291.

On January 31, 1997, NB sent a letter to Larsen and Hagman formally proposing to finance the acquisition of the Facility. The proposed equity and ownership split was 40% for NB and 60% for the partners. NB’s proposal also recognized that an LLC would be used to acquire the Facility. On March 28, 1997, Larsen, on behalf of the MBO Partnership, formed SPLLC. Larsen and Hagman were the initial members, and Larsen the manager, of SPLLC. The Organizing Operating Agreement authorized Larsen to execute a Membership Subscription Agreement between SPLLC and NB and a new operating agreement between SPLLC, NB, da Costa, Larsen, Hagman and others.

After receiving data indicating a decrease in the Facility’s projected financial performance, NB revised the equity and ownership split in its financing proposal such that its share was increased to 70% and the partners’ share was decreased to 30%. However, the partners would retain 60% voting control. The partners attempted in vain to obtain more equity from NB.

Once it became clear that NB would not increase the partners’ equity position, Appellant apparently became unsettled about the transaction. It was Appellant’s opinion that he had more at stake in the venture than the other three partners because he was the only partner relocating his family and incurring significant additional debt. Id. at 334. In an attempt to make up for his reduction in equity, Appellant made various written proposals to the other partners on May 27, 1997. Appellant suggested that SPLLC pay him performance bonuses potentially worth millions of dollars, increase his bonus from $35,000 to $45,000 payable immediately, reimburse him for his daughter’s private school tuition, pay him a $700 a month car allowance, reimburse him for relocation costs, guarantee a minimum selling price for his home in Ohio and execute an employment contract guaranteeing his salary and bonus for at least two years. Id. at 513-18.

The individual defendants reacted negatively to Appellant’s proposals.

Aside from being unwilling to give Appellant a package worth millions of dollars more than their own, they feared that Appellant’s attempt to renegotiate his deal

would jeopardize the MBO Partnership’s ability to finance the acquisition. On May 28, 1997, da Costa wrote to Larsen and Hagman stating that they should give Appellant written notice that he was expelled from the MBO Partnership. Larsen drafted a memo dated May 29, 1997, informing Appellant that he was no longer a partner in the MBO Partnership. However, the memo was never delivered. Rather, at the urging of Walker Poole of NB, the partners met and reconciled. The individual defendants agreed to provide Appellant with a relocation package and Appellant withdrew his other proposals. On June 2, 1997, shortly after the partners had resolved their differences, da Costa sent Appellant an e-mail stating, “I’m delighted you are on board.” Id. at 522. A June 5, 1997, draft of the Subscription Agreement and Representation Letter lists Appellant among the purchasers of membership interests in SPLLC. Id. at 577-80.

Free access — add to your briefcase to read the full text and ask questions with AI

Bowman v. SP Pharmaceuticals, (10th Cir. 2000).

Bowman v. SP Pharmaceuticals (Bowman v. SP Pharmaceuticals) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Citizens Bank of Clovis v. Williams
630 P.2d 1228 (New Mexico Supreme Court, 1981)
GCM, Inc. v. Kentucky Central Life Insurance
947 P.2d 143 (New Mexico Supreme Court, 1997)
Holman v. Coie
522 P.2d 515 (Court of Appeals of Washington, 1974)
Bassett v. Bassett
798 P.2d 160 (New Mexico Supreme Court, 1990)
Levy v. Disharoon
749 P.2d 84 (New Mexico Supreme Court, 1988)
Petty v. Bank of New Mexico Holding Co.
787 P.2d 443 (New Mexico Supreme Court, 1990)
Cargill v. Sherrod
631 P.2d 726 (New Mexico Supreme Court, 1981)
St. Joseph's Regional Health Center v. Munos
934 S.W.2d 192 (Supreme Court of Arkansas, 1996)
Bohatch v. Butler & Binion
977 S.W.2d 543 (Texas Supreme Court, 1998)
Leigh v. Crescent Square, Ltd.
608 N.E.2d 1166 (Ohio Court of Appeals, 1992)
Waite ex rel. Bretton Woods Acquisition Co. v. Sylvester
560 A.2d 619 (Supreme Court of New Hampshire, 1989)